课题基金 / 基金详情

Regulation of tumor promotion by RasGRP1

Regulation of tumor promotion by RasGRP1
RasGRP1 对肿瘤促进的调节
批准号:
6619148
负责人:
PATRICIA S LORENZO
金额:
$10.0万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-08-01 至 2003-07-31

项目摘要

项目成果

PATRICIA S LORENZO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Tumor promotion is a reversible and non-genotoxic stage in carcinogenesis and, as a consequence, the various components of this process are central targets for the development of mechanism-based anti- cancer and chemopreventive drugs. In the mouse skin model of chemical-induced activating mutation in the H-Ras gene. The nature of the interaction between phorbol esters and Ras signaling in tumor promotion has not been defined yet. Although protein kinase C (PKC) has historically been considered responsible for all phorbol ester actions, the discovery of non-PKC receptors casts doubts on the assumption of an exclusive PKC-mediated effect. We have recently characterized the novel Ras activator RasGRP1 as a high affinity receptor for phorbol esters, and our preliminary data indicate that RasGRP1 is expressed in the epidermal keratinocyte, the target cell in chemical carcinogenesis. These data suggest that RasGRP1 may represent a novel and direct link between Ras and phorbol esters can modulate RasGRP1 activity in keratinocytes, and that this modulation contributes to the mechanisms activated by tumor promotion during cancer formation. The specific aims to test the hypothesis are: (1) to define the functional role of RasGRP on the responses induced by phorbol esters in keratinocytes, including growth arrest, differentiation, and apoptosis; (2) to determine if RasGRP1 signaling is altered in initiated (H-Ras-mutated) keratinocytes, either by changes in the level of expression of RasGRP1, changes in substrate affinity, or both; and (3) to establish in vivo models to investigate the role of RasGRP1 in skin carcinogenesis and tumor promotion (knockout and transgenic animals for RasGRP1). Taken together, the results of this study have the potential to unravel a new molecular target for the transmission of phorbol ester-signals involved in carcinogenesis. This information could lead to future approaches for developing novel chemopreventive compounds targeted to tumor promotion events.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
RasGRP1 represents a novel non-protein kinase C phorbol ester signaling pathway in mouse epidermal keratinocytes.
RasGRP1 代表小鼠表皮角质形成细胞中一种新型非蛋白激酶 C 佛波酯信号通路。
DOI: 10.1074/jbc.m308240200
发表时间: 2003
期刊: The Journal of biological chemistry
影响因子: --
作者: [Rambaratsingh,ReshmiA, Stone,JamesC, Blumberg,PeterM, Lorenzo,PatriciaS]
通讯作者: Lorenzo,PatriciaS
Differential effects of bryostatin 1 and 12-O-tetradecanoylphorbol-13-acetate on the regulation and activation of RasGRP1 in mouse epidermal keratinocytes.
苔藓抑素 1 和 12-O-十四烷酰佛波醇-13-乙酸酯对小鼠表皮角质形成细胞中 RasGRP1 的调节和激活的不同作用。
DOI: 10.1158/1535-7163.mct-05-0317
发表时间: 2006
期刊: Molecular cancer therapeutics
影响因子: 5.7
作者: [Tuthill,MatthewC, Oki,CarolynE, Lorenzo,PatriciaS]
通讯作者: Lorenzo,PatriciaS
Molecular signatures of mu opioid receptor and somatostatin receptor 2 in pancreatic cancer.
胰腺癌中MU阿片受体和生长抑素受体2的分子特征。
DOI: 10.1091/mbc.e16-06-0427
发表时间: 2016-11-07
期刊: Molecular biology of the cell
影响因子: 3.3
作者: [Jorand R, Biswas S, Wakefield DL, Tobin SJ, Golfetto O, Hilton K, Ko M, Ramos JW, Small AR, Chu P, Singh G, Jovanovic-Talisman T]
通讯作者: Jovanovic-Talisman T
Ras activation pathways in UVR-induced epidermal transformation
  • 批准号:
    8244396
  • 项目类别:
  • 资助金额:
    $7.5万
  • 财政年份:
    2011
  • 负责人:
    PATRICIA S LORENZO
  • 依托单位:
Regulation of tumor promotion by RasGRP1
  • 批准号:
    7235398
  • 项目类别:
  • 资助金额:
    $25.88万
  • 财政年份:
    2003
  • 负责人:
    PATRICIA S LORENZO
  • 依托单位:
Regulation of tumor promotion by RasGRP1
  • 批准号:
    8294578
  • 项目类别:
  • 资助金额:
    $28.48万
  • 财政年份:
    2003
  • 负责人:
    PATRICIA S LORENZO
  • 依托单位:
Regulation of tumor promotion by RasGRP1
  • 批准号:
    8125991
  • 项目类别:
  • 资助金额:
    $28.48万
  • 财政年份:
    2003
  • 负责人:
    PATRICIA S LORENZO
  • 依托单位:
海外基金